Filed: 11/14/2025ACC: 0001193125-25-281790
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $222.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$222.37M
Total AUM (reported)
22.06M
Total Shares
Allocation by class
COMMON STOCK$189.63M85.3%
COMMON STOCK CLASS A$32.68M14.7%
WARRANT$63.4K0.0%
Portfolio Concentration
Top 3$115.35M51.9%
4–10$105.91M47.6%
11–25$1.11M0.5%
Top 3 weight
51.9%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 22.06M
Sole
Full voting authority
22.06M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
Kestra Med Technologies Ltd
SOLEShares1.65M
TypeSH
Market value$39.11M
17.59%
Sole
1.65M
Shared
0.00
None
0.00
Beta Bionics Inc.
SOLEShares1.92M
TypeSH
Market value$38.15M
17.16%
Sole
1.92M
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics Inc.
SOLEShares3.29M
TypeSH
Market value$38.09M
17.13%
Sole
3.29M
Shared
0.00
None
0.00
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$34.81M
15.66%
Sole
2.20M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares8.83M
TypeSH
Market value$32.68M
14.69%
Sole
8.83M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares1.36M
TypeSH
Market value$25.51M
11.47%
Sole
1.36M
Shared
0.00
None
0.00
ImageneBio, Inc.
SOLEShares455.36K
TypeSH
Market value$3.71M
1.67%
Sole
455.36K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares526.36K
TypeSH
Market value$3.60M
1.62%
Sole
526.36K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.00M
1.35%
Sole
843.75K
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares653.22K
TypeSH
Market value$2.61M
1.17%
Sole
653.22K
Shared
0.00
None
0.00
Replimune Group
SOLEShares248.67K
TypeSH
Market value$1.04M
0.47%
Sole
248.67K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares89.70K
TypeSH
Market value$63.4K
0.03%
Sole
89.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kestra Med Technologies LtdSOLE | Common Stock | 1.65M | SH | $39.11M 17.59% | 1.65M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.92M | SH | $38.15M 17.16% | 1.92M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $38.09M 17.13% | 3.29M | 0.00 | 0.00 |
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $34.81M 15.66% | 2.20M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 8.83M | SH | $32.68M 14.69% | 8.83M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | Common Stock | 1.36M | SH | $25.51M 11.47% | 1.36M | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $3.71M 1.67% | 455.36K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 526.36K | SH | $3.60M 1.62% | 526.36K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.00M 1.35% | 843.75K | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 653.22K | SH | $2.61M 1.17% | 653.22K | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 248.67K | SH | $1.04M 0.47% | 248.67K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 89.70K | SH | $63.4K 0.03% | 89.70K | 0.00 | 0.00 |